4.7 Article

Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia

期刊

LEUKEMIA
卷 28, 期 1, 页码 98-107

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2013.246

关键词

miRNA; DROSHA; miR-15; miR-16; chronic lymphocytic leukemia; CLL; ADARB1

资金

  1. DKFZ [K109]
  2. Sander Foundation [2010.036.1]
  3. Deutsche Jose Carreras Leukamie-Stiftung [R06/13v]
  4. Deutsche Krebshilfe (Max-Eder Programme) [109321]

向作者/读者索取更多资源

The MIR-15A/-16-1 tumor suppressor microRNAs (miRNAs) are deleted in leukemic cells from more than 50% of patients with chronic lymphocytic leukemia (CLL). As these miRNAs are also less abundant in patients without genomic deletion, their downregulation in CLL is likely to be caused by additional mechanisms. We found the primary transcripts (pri-miRNAs) of MIR-15a/-16/-15b to be elevated and processing intermediates (precursor miRNAs) to be reduced in cells from CLL patients (22/38) compared with non-malignant B-cells (n = 14), indicating a block of miRNA maturation at the DROSHA processing step. Using a luciferase reporter assay for pri-miR processing we validated the defect in primary CLL cells. The block of miRNA maturation is restricted to specific miRNAs and can be found in the cell line MEC-2, but not in MEC-1, even though both are derived from the same CLL patient. In these cells, the RNA-specific deaminase ADARB1 leads to reduced pri-miRNA processing, but full processing efficiency is recovered upon deletion of the RNA-binding domains or nuclear localization of ADARB1. Thus, we show that, apart from genomic deletion or transcriptional downregulation, aberrant processing of miRNA leads to specific reduction of miRNAs in leukemic cells. This represents a novel oncogenic mechanism in the pathogenesis of CLL.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据